Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo.
about
Role of Peroxisome Proliferator-Activated Receptors in Inflammation ControlDownregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposisOxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophagesCyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.p38 mediates mechanical allodynia in a mouse model of type 2 diabetes.Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2.Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.Orphan nuclear receptors find a home in the arterial wall.PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?PPAR and immune system--what do we know?PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effectSuppression of macrophage inflammatory responses by PPARs.The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarizationVitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1.Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2)Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptorsObese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?Genomewide effects of peroxisome proliferator-activated receptor gamma in macrophages and dendritic cells--revealing complexity through systems biology.CD97/ADGRE5 Inhibits LPS Induced NF-κB Activation through PPAR-γ Upregulation in Macrophages.Docosahexaenoic acid decreases pro-inflammatory mediators in an in vitro murine adipocyte macrophage co-culture model.Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPARγ.C-reactive protein induces interleukin-6 and thrombospondin-1 protein and mRNA expression through activation of nuclear factor-ĸB in HK-2 cells.1,5-Anhydroglucitol attenuates cytokine release and protects mice with type 2 diabetes from inflammatory reactions.Liv.52 regulates ethanol induced PPARgamma and TNF alpha expression in HepG2 cells.Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiation.15-Deoxy-Delta12,14-prostaglandin J2 regulates endogenous Cot MAPK kinase kinase 1 activity induced by lipopolysaccharide.Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid.15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoterActivated and inactivated PPARs-γ modulate experimentally induced colitis in rats.Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands.Peroxisome proliferator-activated receptor-gamma-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449. Comparison with the effects of 15-deoxy-delta(12,14)-prostaglandin J(2).Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells.PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
P2860
Q24796541-24CBC6CF-9D8E-4C2A-AC3C-0FB760F8A110Q24814458-1FC94CDB-F9FB-4479-AFBF-0C426AFAF8C7Q28348220-D3937B82-CD06-4CBA-9286-E301C6913505Q33644063-FC328AB7-D1D7-45B7-AAD8-1367AC72EC8DQ33895067-DA4F4D9F-CC33-45F1-A17C-611B43E1569BQ34077992-5E0DED6D-7517-4587-A5C0-3D7AE7173B45Q34290988-8D780779-2A5D-47C6-BF42-90DE0FB56BA9Q34509942-5C3511B3-769B-404B-9B8A-C01AD804D688Q34580424-ED6F7EFF-2793-4BEB-B6B6-972A37594404Q34586834-31B6EF62-B150-4E07-B46F-33CD4EC67942Q34722604-CB347EB6-6048-4E63-9124-08309278A88DQ34913467-053AAFBC-1FF8-4FCD-AFC5-1E71C1C74585Q35045267-15055773-0945-4199-8564-641D4CAC39ECQ35142657-5FA91324-23BE-4673-9A7B-32AB80CEBB87Q35600280-4BC015EF-54D8-4BEB-AABC-DACF11BDEB7CQ36011499-64F36B2C-50AD-449B-BE1E-12CC623ED77BQ36063833-B8A81D3D-B513-4B13-8A23-DAE98C92D793Q36171381-5F53150E-5666-40EA-A0DC-209663CACA5FQ36631061-E40CF3B3-73DA-41B5-AD92-BF73277CF023Q36687379-45AA8FCA-3D71-4C41-8DF9-F9C7972DC0E4Q36712237-95755565-4C7F-4C1F-8830-EABBC2581E7EQ36733873-465B4213-44A5-49FF-8753-18C1E3FF5E52Q36807630-21731C78-B453-4E75-B8AC-261EE552D06EQ38489705-8C6FBD9C-B5E3-4FF2-BCA4-CB92A75201D0Q38562247-5CAFE34C-B0E7-4EFA-A114-C451ADB1ED54Q38796645-2E97EA67-085D-4486-AF37-798777B359B5Q39030375-402E84DF-85AC-4CE5-9A48-B3900909C509Q39264389-0C2B5E82-68B1-423B-A987-AF06C337292CQ39416709-F989C9E4-CA30-4540-B9BE-CE2E122610AEQ39717154-00C30D1B-7713-4EBE-A06C-BE2F306C7EB5Q39986574-64EA0B02-201C-478B-A0AA-51C2D7892F6AQ40498186-58F4827F-F8DC-452C-89B4-7A3BF23076FFQ40626535-115A44F6-937C-48F2-9C38-A6CD10215089Q40627969-9AC1ECA8-7E18-4C3E-ABA1-AD6854A1F598Q41894078-B5393777-B9B8-4334-83B1-4BDE2DCDCB98Q42256152-4F82A16A-B697-4203-83CD-554F41F34F2CQ42834098-8F6C6985-3B34-43C8-ABB1-E3B74B8ADCA8Q43662741-29ECE619-FE16-4378-8323-E24AE5F82B91Q43760306-C18D362B-146A-4435-A60E-66B51CF5C062Q43822295-0146A4BC-DFF2-42F6-AF2F-C5E849D4D6A1
P2860
Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Activation of peroxisome proli ...... accharide in vitro or in vivo.
@en
type
label
Activation of peroxisome proli ...... accharide in vitro or in vivo.
@en
prefLabel
Activation of peroxisome proli ...... accharide in vitro or in vivo.
@en
P2093
P921
P1476
Activation of peroxisome proli ...... accharide in vitro or in vivo.
@en
P2093
Detmers PA
Fenyk-Melody JE
Le Grand CB
Shelton BA
Thieringer R
P304
P356
10.4049/JIMMUNOL.164.2.1046
P407
P577
2000-01-01T00:00:00Z